Itonic Holdings Ltd. (NASDAQ:ITOC) Sees Large Increase in Short Interest

Itonic Holdings Ltd. (NASDAQ:ITOC) saw a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 344,406 shares, a growth of 115.6% from the April 15th total of 159,717 shares. Currently, 2.0% of the company’s shares are short sold. Based on an average daily trading volume, of 4,386,228 shares, the short-interest ratio is presently 0.1 days.

Itonic Trading Down 2.3%

NASDAQ:ITOC opened at $0.30 on Friday. The company has a 50-day moving average price of $0.33. Itonic has a 1-year low of $0.25 and a 1-year high of $32.00.

Itonic (NASDAQ:ITOC) last announced its quarterly earnings results on Monday, March 30th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $0.23 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Itonic in a research note on Friday, May 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.